Here are the DEF 14A proxy statements from Opko Health Inc. (OPK) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow OPK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OPK filings page.
OPKO Health is calling a virtual 2026 annual stockholder meeting on June 18, 2026, asking investors to elect 11 directors, approve a new 2026 Equity Incentive Plan, give an advisory Say on Pay vote, and ratify Ernst & Young LLP as auditor for 2026.
Stockholders of record on April 20, 2026, holding 755,092,256 outstanding common shares, are entitled to one vote per share and may vote online, by phone, or by mail. The proxy details a board where independent directors form a majority and chair all key committees, and shows significant insider and large‑holder ownership, including 33.31% beneficial ownership by CEO Phillip Frost, M.D.